Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Buoy vs fatty15

An in-depth comparison of two leading Supplements

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.2

Buoy

Best for GLP-1-companion electrolyte supplement
★★★3.6

Starting at $30/mo

ElectrolytesHydrationGLP-1 CompanionSugar-Free
Visit Buoy
6.7

fatty15

Best for single-ingredient C15:0 longevity supplement
★★★☆☆3.4

Starting at $50/mo

C15:0LongevityCellular HealthInflammation
Visit fatty15

Side-by-Side Comparison

FeatureBuoyfatty15
Overall Score7.2/106.7/10
Starting Price$30/mo$50/mo
Editorial Rating3.6 ★ /53.4 ★ /5
Features4 features4 features
States Available00
Compounded
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Buoy

Pros

  • Liquid format mixes into any beverage — easier compliance than electrolyte powders
  • Sugar-free / no artificial sweeteners (per brand positioning)
  • Useful adjunct for GLP-1 patients who experience electrolyte loss from reduced appetite and rapid weight loss

Cons

  • Stub entry — exact pricing, ingredient panel per serving, and clinical positioning need a YMYL verification pass
  • Confidence is LOW until that pass is done
  • Not a substitute for prescription electrolyte management in clinically significant cases

fatty15

Pros

  • Single-ingredient supplement with a clear mechanism (C15:0 cell-membrane stability) and a published research portfolio behind it
  • Strong brand-recognition lever — fatty15 has run high-profile longevity-content marketing through 2024-2025
  • Pure C15:0 is hard to sourcefrom diet alone (mainly found in dairy fat) so supplementation has a defensible nutritional rationale for some patients

Cons

  • Stub entry — exact pricing, ingredient panel, third-party lab testing, FDA / FTC adverse actions, and the longevity / metabolic claims all need a YMYL verification pass
  • Confidence is LOW until that pass is done
  • C15:0 essential-fatty-acid status is the company's own positioning; independent peer-reviewed consensus on whether it should be classified as essential is still developing
  • Not a weight-loss product per se — listed here because longevity / cellular health overlaps with our metabolic-health editorial scope, not because it directly causes weight loss

Our Verdict

Winner: BuoyScore: 7.2/10

Buoy edges out fatty15 with a higher overall score of 7.2/10 and is particularly strong for GLP-1-companion electrolyte supplement. fatty15 remains a solid alternative, especially if you're looking for single-ingredient C15:0 longevity supplement.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.